{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:46:51Z","timestamp":1792799211566,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Landsforeningen for Huntingtons Sygdom"},{"name":"The Research Board at Rigshospitalet"},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010359","name":"L\u00e6ge S\u00f8ren Segel og Hustru Johanne Wiibroe Segels Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Huntington\u2019s disease (HD) is clinically characterized by progressing motor, cognitive and psychiatric symptoms presenting as varying phenotypes within these three major symptom domains. The disease is caused by an expanded CAG repeat tract in the huntingtin gene and the pathomechanism leading to these endophenotypes is assumed to be neurodegenerative. In 2012\/2013 we recruited 107 HD gene expansion carriers (HDGECs) and examined the frequency of the three cardinal symptoms and in 2017\/2018 we followed up 74 HDGECs from the same cohort to describe the symptom trajectories and individual drift between the endophenotypes as well as potential predictors of progression and remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found higher age to reduce the probability of improving on psychiatric symptoms; increasing disease burden score ((CAG-35.5)\u00a0*\u00a0age) to increase the risk of developing cognitive impairment; increasing disease burden score and shorter education to increase the risk of motor onset while lower disease burden score and higher Mini Mental State Examination increased the probability of remaining asymptomatic. We found 23.5% (N\u2009=\u20098) to improve from their psychiatric symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is no clear pattern in the development of or drift between endophenotypes. In contrast to motor and cognitive symptoms we find that psychiatric symptoms may resolve and thereby not entirely be caused by neurodegeneration. The probability of improving from psychiatric symptoms is higher in younger age and advocates for a potential importance of early treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-021-01967-2","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T05:33:08Z","timestamp":1628832788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endophenotypical drift in Huntington\u2019s disease: a 5-year follow-up study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-1073","authenticated-orcid":false,"given":"Marie N. N.","family":"Hellem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tua","family":"Vinther-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida U.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Hjermind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmus","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"1967_CR1","doi-asserted-by":"crossref","unstructured":"Ghosh R, Tabrizi SJ. Clinical Aspects of Huntington\u2019s Disease. In: Geyer MA, Ellenbroek BA, Marsden CA, Barnes TRE, Nguyen HHP, Cenci MA, editors. Behavioral Neurobiology of Huntington\u2019s Disease and Parkinson\u2019s Disease. Berlin: Springer Berlin Heidelberg; 2013. p. 3\u201331.","DOI":"10.1007\/7854_2013_238"},{"issue":"4","key":"1967_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/1039856218791036","volume":"26","author":"AMY Goh","year":"2018","unstructured":"Goh AMY, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JCL. Huntington\u2019s disease: neuropsychiatric manifestations of Huntington\u2019s disease. Australas Psychiatry. 2018;26(4):366\u201375.","journal-title":"Australas Psychiatry"},{"key":"1967_CR3","doi-asserted-by":"crossref","unstructured":"Vinther-Jensen T, Nielsen TT, Budtz-J\u00f8rgensen E, Larsen IU, Hansen MM, Hasholt L, et al. Psychiatric and cognitive symptoms in Huntington\u2019s disease are modified by polymorphisms in catecholamine regulating enzyme genes. Clin Genet. 2016;89(3):320\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26081309.","DOI":"10.1111\/cge.12628"},{"issue":"4","key":"1967_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E van Duijn","year":"2007","unstructured":"van Duijn E, Kingma E, van der Mast MR. Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci [Internet]. 2007;19(4):441\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci [Internet]."},{"issue":"1110","key":"1967_CR5","first-page":"204","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Publ Gr. 2014;10(1110):204\u201316.","journal-title":"Nat Publ Gr"},{"issue":"4","key":"1967_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/jnp.14.4.377","volume":"14","author":"DR Royall","year":"2002","unstructured":"Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, et al. Executive control function. J Neuropsychiatry Clin Neurosci. 2002;14(4):377\u2013405.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7","key":"1967_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study\u202f: analysis of 36-month observational data. Lancet Neurol [Internet]. 2013;12(7):637\u201349. https:\/\/doi.org\/10.1016\/S1474-4422(13)70088-7.","journal-title":"Lancet Neurol [Internet]."},{"issue":"3","key":"1967_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1176\/jnp.2007.19.3.310","volume":"19","author":"MNW Witjes-An\u00e9","year":"2007","unstructured":"Witjes-An\u00e9 MNW, Mertens B, Van Vugt JPP, Bachoud-L\u00e9vi AC, Van Ommen GJB, Roos RAC. Longitudinal evaluation of \u201cPresymptomatic\u201d carriers of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2007;19(3):310\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"1967_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","volume":"24","author":"JC Thompson","year":"2012","unstructured":"Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, et al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2012;24(1):53\u201360.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"12","key":"1967_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry [Internet]. 2007;62(12):1341\u20136.","journal-title":"Biol Psychiatry [Internet]."},{"key":"1967_CR11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14121551","author":"EA Epping","year":"2015","unstructured":"Epping EA, Kim J-I, Craufurd D, Brashers-Krug TM, Anderson KE, McCusker E, et al. Longitudinal psychiatric symptoms in prodromal Huntington\u2019s disease: a decade of data. Am J Psychiatry [Internet]. 2015. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14121551.","journal-title":"Am J Psychiatry [Internet]."},{"key":"1967_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","volume":"9","author":"T Vinther-Jensen","year":"2014","unstructured":"Vinther-Jensen T, Larsen IU, Hjermind LE, Budtz-J\u00f8rgensen E, Nielsen TT, N\u00f8rrem\u00f8lle A, et al. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington\u2019s disease. Orphanet J Rare Dis. 2014;9:114.","journal-title":"Orphanet J Rare Dis"},{"key":"1967_CR13","doi-asserted-by":"crossref","unstructured":"Vinther-Jensen T, Larsen IU, Hjermind LE, Budtz-J\u00f8rgensen E, Nielsen TT, N\u00f8rrem\u00f8lle A, et al. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington\u2019s disease. Orphanet J Rare Dis. 2014;9:114.\u00a0","DOI":"10.1186\/s13023-014-0114-8"},{"key":"1967_CR14","doi-asserted-by":"crossref","unstructured":"Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, et al. Unified Huntington\u2019s Disease Rating Scale: Reliability - and-Consistency. Mov Disord. 1996;11(2):136\u201342.","DOI":"10.1002\/mds.870110204"},{"issue":"5","key":"1967_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney JB, Vonsattel J-P, Macdonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol [Internet]. 1997;41(5):689\u201392. https:\/\/doi.org\/10.1002\/ana.410410521.","journal-title":"Ann Neurol [Internet]."},{"issue":"8","key":"1967_CR16","first-page":"935","volume":"251","author":"J Lemiere","year":"2004","unstructured":"Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington\u2019s disease (HD) and asymptomatic carriers of the HD mutation\u2014a longitudinal follow-up study. J Neurol [Internet]. 2004;251(8):935\u201342.","journal-title":"J Neurol [Internet]."},{"issue":"2","key":"1967_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.wnn.0000152205.79033.73","volume":"18","author":"LJ Beglinger","year":"2005","unstructured":"Beglinger LJ, Nopoulos PC, Jorge RE, Langbehn DR, Mikos AE, Moser DJ, et al. White matter volume and cognitive dysfunction in early Huntington\u2019s disease. Cogn Behav Neurol. 2005;18(2):102\u20137.","journal-title":"Cogn Behav Neurol"},{"key":"1967_CR18","doi-asserted-by":"crossref","unstructured":"Dorszewska J, Kozubski W, Waleszczyk W, Zabel M, Ong K. Neuroplasticity in the pathology of neurodegenerative diseases. Neural Plast. 2020;2020:4245821\u20132.","DOI":"10.1155\/2020\/4245821"},{"issue":"1","key":"1967_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.371","volume":"4","author":"CA Cooper","year":"2017","unstructured":"Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, et al. Common variant rs356182 near SNCA defines a Parkinson\u2019s disease endophenotype. Ann Clin Transl Neurol. 2017;4(1):15\u201325.","journal-title":"Ann Clin Transl Neurol"},{"key":"1967_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","volume":"52","author":"C Mo","year":"2015","unstructured":"Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington\u2019s disease. Neurosci Biobehav Rev [Internet]. 2015;52:178\u201392. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.03.003.","journal-title":"Neurosci Biobehav Rev [Internet]."},{"issue":"12","key":"1967_CR21","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/mds.25980","volume":"29","author":"CD Moulton","year":"2014","unstructured":"Moulton CD, Hopkins CWP, Bevan-Jones WR. Systematic review of pharmacological treatments for depressive symptoms in Huntington\u2019s disease. Mov Disord. 2014;29(12):1556\u201361.","journal-title":"Mov Disord"},{"issue":"1","key":"1967_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-2010-1237","volume":"19","author":"GA Jicha","year":"2010","unstructured":"Jicha GA, Carr SA. Conceptual evolution in Alzheimer\u2019s disease: Implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimer\u2019s Dis. 2010;19(1):253\u201372.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"1967_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol [Internet]. 2012;11(1):42\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(11)70263-0.","journal-title":"Lancet Neurol [Internet]."},{"issue":"9","key":"1967_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol [Internet]. 2009;8(9):791\u2013801. https:\/\/doi.org\/10.1016\/S1474-4422(09)70170-X.","journal-title":"Lancet Neurol [Internet]."},{"issue":"1","key":"1967_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RAC, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurol [Internet]. 2011;10(1):31\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(10)70276-3.","journal-title":"Lancet Neurol [Internet]."},{"issue":"2","key":"1967_CR26","first-page":"1007","volume":"1","author":"NF Mehrabi","year":"2016","unstructured":"Mehrabi NF, Singh-Bains MK, Waldvogel HJ, Faull RL. Cortico-Basal Ganglia interactions in Huntington\u2019s disease. Ann Neurodegener Disord [Internet]. 2016;1(2):1007.","journal-title":"Ann Neurodegener Disord [Internet]."},{"issue":"6","key":"1967_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11920-004-0010-3","volume":"6","author":"SR Chamberlain","year":"2004","unstructured":"Chamberlain SR, Sahakian BJ. Cognition in mania and depression: psychological models and clinical implications. Curr Psychiatry Rep. 2004;6(6):451\u20138.","journal-title":"Curr Psychiatry Rep"},{"key":"1967_CR28","doi-asserted-by":"crossref","unstructured":"The U.S.\u2013Venezuela Collaborative Research Project, Wexler NS. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA [Internet]. 2004;101(10):3498\u2013503. Available from: http:\/\/www.pnas.org\/content\/101\/10\/3498.abstract.","DOI":"10.1073\/pnas.0308679101"},{"issue":"2","key":"1967_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tics.2011.11.016","volume":"16","author":"D Ansari","year":"2012","unstructured":"Ansari D. Culture and education: new Frontiers in brain plasticity. Trends Cogn Sci [Internet]. 2012;16(2):93\u20135. https:\/\/doi.org\/10.1016\/j.tics.2011.11.016.","journal-title":"Trends Cogn Sci [Internet]"},{"issue":"6","key":"1967_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, et al. Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci. 2017;7(6):1\u201315.","journal-title":"Brain Sci"},{"issue":"4","key":"1967_CR31","first-page":"219","volume":"14","author":"D Craufurd","year":"2001","unstructured":"Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington disease. Neuropsychiat Neuropsychol Behav Neurol. 2001;14(4):219\u201326.","journal-title":"Neuropsychiat Neuropsychol Behav Neurol"},{"key":"1967_CR32","doi-asserted-by":"crossref","unstructured":"Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet Part B Neuropsychiatr Genet. 156B(7):751\u201363.","DOI":"10.1002\/ajmg.b.31232"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01967-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T11:58:22Z","timestamp":1725623902000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01967-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the ethics committee of the Capital region of Denmark (H-17002606) and written informed consent was obtained from each participant before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}